Gankyrin Drives Malignant Transformation of Gastric Cancer and Alleviates Oxidative Stress via mTORC1 Activation

Table 2

Association between gankyrin expression and clinicopathological features.

Clinicopathological features	No. of patients ()	Relative gankyrin expression
		High	Low
Age				0.785	0.435
<45	9	5 (55.6%)	4 (44.4%)
≥45	68	39 (57.4%)	29 (42.6%)
Gender				1.898	0.062
Male	52	34 (65.4%)	18 (34.6%)
Female	25	11 (44.0%)	14 (56.0%)
Lymph node metastasis				2.401	0.019
No	20	9 (45.0%)	11 (55.0%)
Yes	57	35 (61.4%)	22 (38.6%)
Distant metastasis				2.532	0.013
No	55	27 (49.1%)	28 (50.9%)
Yes	22	17 (77.3%)	5 (22.7%)
Pathological grade				2.557	0.084
I–II	9	7 (77.8%)	2 (22.2%)
III	62	34 (54.8%)	28 (45.2%)
IV	6	3 (50.0%)	3 (50.0%)
Vascular invasion				2.122	0.037
No	20	9 (45.0%)	11 (55.0%)
Yes	57	35 (61.4%)	22 (38.6%)

Patients were divided by high gankyrin staining (H-score ≥ 145) and low gankyrin staining (H-score < 145).